UBS MSCI Switzerland 20/35 UCITS ETF hGBP acc

What this fund is

UBS MSCI Switzerland 20/35 UCITS ETF hGBP acc is an exchange-traded fund (ETF) from UBS, traded under the ticker UC93 (ISIN LU1169830525). One trade buys a whole basket of holdings, so your money is spread out instead of riding on a single company. In plain terms it is about owning small slices of companies, so you share in their growth when they do well — and their falls when they don't, focused on the European market. Rather than a manager picking stocks, it simply replicates the MSCI Switzerland 20/35 index — the passive, low-cost approach, and its largest holdings include ROCHE HLDG PC PRP, NOVARTIS AG-REG and NESTLE SA-REG. Geographically it leans ~75.2% Switzerland.

Its heaviest sectors are ~30.6% Health Care and ~15.5% Financials. Investors often use a broad fund like this as a long-term 'core' holding — a single building block that covers much of a global portfolio in one trade. Its ongoing charge (TER) is 0.23% a year — about €23 a year on a €10,000 holding, taken automatically from the fund. Income such as dividends is automatically reinvested inside the fund (an accumulating share class), so returns compound without you doing anything. It holds the underlying investments directly (physical replication); it is domiciled in Luxembourg and UCITS-regulated, a European standard built to protect everyday investors and trades in GBP.

Its price has swung about 12.5% over the past year, which describes how much its price tends to move rather than whether it is good. It launched in 2015. As with any investment, its value can go down as well as up, and past performance is not a guide to future results. (Fund data sourced from UBS.)